ZyVersa Therapeutics News

8-K: Current report

Apr 25 16:38 ET

8-K: Current report

Apr 17 16:37 ET

ZyVersa Therapeutics | DEFA14A: Others

Mar 27 17:05 ET

ZyVersa Therapeutics | DEF 14A: Definitive information statements

Mar 19 17:29 ET

ZyVersa Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 8 17:02 ET

ZyVersa Therapeutics | 8-K: Current report

Mar 8 17:02 ET

ZyVersa Therapeutics | 8-K: Current report

Mar 1 16:36 ET

ZyVersa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 14 16:43 ET

ZyVersa Therapeutics | 8-K: Current report

Dec 22, 2023 16:45 ET

ZyVersa Therapeutics | 8-K: Current report

Dec 11, 2023 16:30 ET

ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 6, 2023 16:13 ET

ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 4, 2023 19:20 ET

ZyVersa Therapeutics | 8-K: Current report

Nov 30, 2023 11:45 ET

ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 21, 2023 16:20 ET

ZyVersa Therapeutics | 8-K: Current report

Nov 17, 2023 16:15 ET

ZyVersa Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Nov 3, 2023 17:16 ET

ZyVersa Therapeutics | 8-K: Current report

Nov 2, 2023 16:37 ET

ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 17, 2023 16:15 ET

ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 5, 2023 17:27 ET

ZyVersa Therapeutics | 8-K/A: Current report (Amendment)

Sep 20, 2023 17:15 ET